about
Evolution of drugs that preserve renal function.Effects of noradnamine (5-aminomethyl-2,3,7,8-tetrahydroxydibenzo-[a,e[cycloheptatriene) on the blood pressure of the anaesthetized cat and rat.The action of guanethidine on the adrenal medulla of the catSignificance of plasma dopamine beta-hydroxylase activity as an index of sympathetic neuronal function.Factors influencing the adrenergic neurone blocking action of propranolol.Guanethidine-induced vasodilatation in the rabbit, mediated by endogenous histamine.Prevention by guanethidine analogues of output of noradrenaline induced by sodium reduction in rabbit ventricular slicesRestoration of tyramine responses by bretylium, BW392C60, bethanidine and monoamine oxidase inhibitors in reserpine-treated ratsActions of bretylium tosylate at the neuromuscular junction.Prejunctional actions of some beta-adrenoreceptor antagonists in the vas deferens preparation of the guinea-pig.Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man.Guanethidine and guanacline on the rat vas deferens.An analysis of the peripheral effects of l-DOPA on autonomic nerve functionThe central action of antihypertensive drugs, mediated via central alpha-receptors.Comparative studies of (--)-, (+/-)-propranolol, atenolol, guanethidine, bretylium and tetracaine on adrenergic transmission.Blood pressure responses to adrenal field stimulation as a measure of adrenal catecholamine release.Action of guanethidine on rabbit atrial membranes.Further evidence for the prevention by guanethidine of noradrenaline efflux from rabbit ventricular slices induced by a low external sodium concentration.Adrenergic influences on the electrical potential across the colonic mucosa of the rabbit.The antagonism of adrenergic neurone blockade by amphetamine and dexamphetamine in the rat and guinea-pigInhibition of brain cholinesterase activity after the injection of organophosphorus compounds in the rat.The uptake of adrenergic neurone blocking drugs.Metabolic inhibition in primary cell cultures by lipid-soluble molecules.Relative susceptibility of peripheral sympathetic nerves to adrenergic neurone blockade by bethanidine.Action of prostaglandin E 1 on the longitudinal muscle of the guinea-pig isolated colon.The biphasic action of bethanidine in the human eye.Effects of nicotine on salivary amylase secretion from rabbit parotid glandThe effects of nicotine on spontaneous contractions of cat urinary bladder in situ.Adrenergic neurone blocking agents: tolerance and hypersensitivity to adrenaline and noradrenaline.The discovery of bretylium and bethanidine.Guanethidine after twenty years: a pharmacologist's perspective.Evidence for co-transmitter role of neuropeptide Y in the pig spleen.Effects of adrenergic neurone blocking agents on voluntary muscle stimulated at different frequencies.The action of adrenergic neurone blocking agents and other drugs on the pressor responses of various agents in the anaesthetized rat.Further studies on the adrenergic neuron blocking activity of some -adrenoceptor antagonists and guanethidine.
P2860
Q34024129-0451A958-8501-4E2D-8EEB-B76AC2D12867Q35011615-7AB8C563-2F27-4CB8-94D6-F727747651FFQ35039622-F837174B-ADBB-4DEE-A655-CA0C95078725Q35115676-46CE9F13-6A1B-4D89-9222-1D6F844A0B75Q35174327-B404B9F4-4050-42EE-A245-1D31C2CA5219Q35177043-74CA863A-E9F2-4BC1-A19E-81900096886FQ35177632-C9BAEF40-0D13-461D-A060-D7348977DCF8Q35225865-C4654350-AF9D-4147-8047-2B88FFE59EEEQ35226056-28299A18-F6B4-43C4-8D00-4F594F695B72Q35226453-FA5557FB-3A5C-4C9C-AF66-8CA6959755A8Q35579591-9517EC01-532F-45DA-A1B6-A2D272274D02Q35601327-51F592B4-2103-4FCB-A1A4-9D6959336551Q35601371-957CAD3E-6C88-4673-87CB-73AC81FDC026Q39873050-736355EB-3C25-4F59-886E-E0B5D9A6BE83Q39930439-3CF0F6E6-E81F-4990-95A6-D933A5AD66CCQ40013074-229B2E98-39DE-44B2-8971-D068ED5A2C12Q40052066-C3BCFD82-18D5-4BCA-8BB6-1A4194205FECQ40053344-275FEF02-FB77-464D-B950-14CEF9B22D53Q40343783-2BE3EFA8-D2E1-412A-873B-290673385B72Q41292018-262B4961-2FE0-4EB6-AAA5-D5C0092BBF53Q41297515-2C91E192-FB5F-4482-9C51-3629192B213DQ41300546-8C009FCD-3EF6-48DE-A49B-62C15D1140B4Q41338830-BE6DB525-9CD5-4120-8E18-9355D7DE6F9AQ41341212-CA6DED5A-CA69-4B0B-B8FB-F36F1FC6A4E3Q41344775-F9BF90CC-3A98-4E92-8F5E-76A36CAF1BEAQ41345975-834470B5-0142-4627-BF86-DD40E44C461EQ41347169-C923463C-C852-4F50-9235-9CE8722D8B40Q41740819-5F25AE65-76B0-471B-B7BD-0BA019D970FAQ41787394-4273DFE1-0459-476B-A85C-AA238A75A973Q41815856-DF0F74D2-3F0C-4A05-819A-9507885E48B4Q41910124-FCE069D7-A24F-4F31-B15A-05F8CED3CD5CQ42106911-62720D38-1960-4E06-82FE-D0554311DC73Q42372636-9FEA65BE-02C4-42D3-9ECD-FD803F2FCF0DQ43045100-2FAE35F9-0811-4F1C-B5F0-625647138345Q46423614-50FAB0FF-6A70-456A-9E33-CCBDF76EBAA3
P2860
description
1965 nî lūn-bûn
@nan
1965 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1965 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1965年の論文
@ja
1965年論文
@yue
1965年論文
@zh-hant
1965年論文
@zh-hk
1965年論文
@zh-mo
1965年論文
@zh-tw
1965年论文
@wuu
name
ADRENERGIC NEURONE BLOCKING AGENTS.
@ast
ADRENERGIC NEURONE BLOCKING AGENTS.
@en
type
label
ADRENERGIC NEURONE BLOCKING AGENTS.
@ast
ADRENERGIC NEURONE BLOCKING AGENTS.
@en
prefLabel
ADRENERGIC NEURONE BLOCKING AGENTS.
@ast
ADRENERGIC NEURONE BLOCKING AGENTS.
@en
P1476
ADRENERGIC NEURONE BLOCKING AGENTS.
@en
P2093
P304
P356
10.1146/ANNUREV.PA.05.040165.001151
P577
1965-01-01T00:00:00Z